ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION [PDF]
Рациональная фармакотерапия в кардиологии, 2016 Aim. To assess propafenone antiarrhythmic efficacy and optimal timing of the drug administration for relief of persistent atrial fibrillation (PAF). Material and methods.
R. D. Kurbanov +2 more
doaj +4 more sources
Propafenone Induced Takotsubo Cardiomyopathy: A Mere Coincidence or A New Causal Relationship? [PDF]
Düzce Tıp Fakültesi Dergisi, 2023 Propafenone is a class 1C antiarrhythmic drug that blocks sodium channels and is used in the treatment of arrhythmia. Because of its rapid effect on terminating paroxysmal episodes of atrial fibrillation, it can be used as a pill-in-the-pocket.
Adem Adar, Fahri Çakan
doaj +2 more sources
Propafenone is associated with fewer recurrences of supraventricular arrhythmias in mechanically ventilated patients with septic shock and right ventricular dysfunction [PDF]
Frontiers in Cardiovascular MedicineIntroductionSupraventricular arrhythmias (SVA) are common in mechanically ventilated patients with septic shock and may be aggravated by right ventricular (RV) dysfunction. Optimal rhythm-control strategies in this setting remain uncertain.
M. Balik +8 more
doaj +2 more sources
Experience of using propafenone in newborns and young children with arrhythmias [PDF]
Российский кардиологический журнал, 2020 Aim. To evaluate the efficacy and safety of propafenone therapy in newborns and young children, including children with congenital heart defects (CHD).Material and methods.
T. K. Kruchina +3 more
doaj +2 more sources
Pharmacokinetics of propafenone hydrochloride sustained-release capsules in male beagle dogs
Acta Pharmaceutica Sinica B, 2015 This paper describes the development and validation of a liquid chromatography–mass spectrometric assay for propafenone and its application to a pharmacokinetic study of propafenone administered as a new propafenone hydrochloride sustained-release ...
Li Ding
exaly +3 more sources
The novel ortho-chloro derivate propafenone induced relaxation in isolated rat aorta [PDF]
Acta Veterinaria, 2013 The information on the inhibitory effect of propafenone in vascular smooth muscle is sparse. Propafenone acts through blockage of voltage-dependent cardiac Na+ channels, L-type Ca2+ channels, voltage-sensitive K+ (Kv) channels, as well as β-adrenergic
Ivković Branka +7 more
doaj +1 more source
Propafenone-induced liver injury in an elderly patient with paroxysmal atrial fibrillation--a new case report and literature review [PDF]
Acta Poloniae Pharmaceutica, 2023 Antiarrhythmic drugs are used more and more often, which is related to the aging of the population and the growing number of arrhythmias, especially atrial fibrillation (AF).
Katarzyna Giedzicz +5 more
doaj +1 more source
Clinical and Translational Science, 2022 Propafenone is an antiarrhythmic drug metabolized primarily by cytochrome P450 2D6 (CYP2D6). In adults, propafenone adverse events (AEs) are associated with CYP2D6 poor metabolizer status; however, pediatric data are lacking.
Sudeep D. Sunthankar +5 more
doaj +1 more source
Antiarrhythmic effects of newly developed propafenone derivatives [PDF]
Arhiv za farmaciju, 2022 It is well known that the presence of different chemical groups in drug molecules influences their pharmacological properties. The aim of our study is to investigate whether newly synthesized derivatives of propafenone, with changes in benzyl moiety ...
Ivković Branka +4 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Objective: To determine using a systematic assessment and meta-analysis if GFA injection is an appropriate substitute of propafenone for arrhythmic.Design: Conduct a systematic review and meta-analysis of randomized controlled trials.Data Source: PubMed,
Jinming Song +5 more
doaj +1 more source